Table 1.
Demographics, hemodynamic and CTPA data
| IPAH | Sch-PAH | p | |
|---|---|---|---|
| Gender | |||
| Male | 4 (16 %) | 4 (18 %) | ns |
| Female | 21 (84 %) | 18 (81 %) | |
| Age | 40 ± 13 | 48 ± 13 | 0.019 |
| Functional class | |||
| I/II | 7 (28 %) | 7 (32 %) | ns |
| III/IV | 18 (72 %) | 15 (68 %) | |
| Hemodynamics | |||
| mPAP (mmHg) | 63 ± 23 | 56 ± 23 | ns |
| RAP (mmHg) | 15 ± 11 | 9 ± 4 | 0.018 |
| PAOP (mmHg) | 12 ± 6 | 15 ± 7 | ns |
| PVR (IU) | 15.4 ± 5.1 | 10.2 ± 6.1 | 0.009 |
| CO (mL/min) | 4.9 ± 1.8 | 3.8 ± 1.2 | 0.03 |
| CTPA measurements | |||
| MPAD, cm | 3.7 ± 1.1 | 4.5 ± 1.8 | 0.018 |
| RPAD, cm | 2.58 ± 0.47 | 3.16 ± 0.91 | 0.009 |
| LPAD, cm | 2.5 ± 0.4 | 2.7 ± 0.6 | ns |
IPAH idiopathic pulmonary arterial hypertension, Sch-PAH schistosomiasis associated pulmonary hypertension, NYHA FC New York Heart Association functional class, mPAP mean pulmonary arterial pressure, RAP right atrial pressure, PAOP pulmonary artery occlusion pressure, PVR pulmonary vascular resistance, CO cardiac output, MPAD main pulmonary artery diameter, RPAD right pulmonary artery diameter, LPAD left pulmonary artery diameter, ns non significant